British pharmaceutical company GSK has agreed to pay $2.3 billion to settle lawsuits alleging that its heart burn medication Zantac caused cancer. GSK has settled 80,000 Zantac lawsuit. Watch to know more.

Pharmaceutical Giant GSK Reaches Major Settlement

British pharmaceutical company GSK said on Wednesday that it has agreed to pay $2.3 billion to put an end to lawsuits in the United States alleging that its heartburn drug Zantac caused cancer.

Pharma company GSK agrees to pay $2.3bn in US settlements on lawsuits over Zantac cancer claims

A lawsuit against the makers of Zantac was dropped ahead of the trial which was scheduled to start on the 22nd of August in a US court. This comes after a series of court settlements when some of the drug makers were involved.

Zantac contaminated with a cancer-causing chemical, lawsuit dropped ahead of trial

The first jury trial in the United States involving the popular drug Zantac ended in a settlement worth more than $500,000. The four generic makers of the drug — Teva Pharmaceutical Industries Ltd.

First lawsuit accusing Zantac of causing cancer ends in $500,000 settlement

zantac

Zantac, News on Zantac, stories on Zantac, articles on Zantac, Zantac stories at Wion, Zantac news, Zantac latest news